As TUBO cells express activated/mutated rat-neu being a foreign antigen in WT BALB/c, this tumour cells potentially triggers anti-rat-neu adaptive immunity which contributes to anti-neu mAb therapy. The gene discussed is ERBB2; the disease is neoplasm.